Large-scale testing (Phase 3)Not Yet RecruitingNCT07385079
What this trial is testing
Anlotinib Plus Immunotherapy and Chemoradiotherapy for High-Risk Nasopharyngeal Carcinoma
Who this might be right for
Nasopharyngeal Cancinoma (NPC)Nasopharyngeal Cancer
Sun Yat-sen University 412